Submit Manuscript  

Article Details


Current Choice for LDL-C Lowering in High-Risk CVD Patients Intolerant to Statins

[ Vol. 19 , Issue. 4 ]

Author(s):

Zlatko Fras*   Pages 398 - 402 ( 5 )

Keywords:

Atherosclerosis, statin intolerance, ezetimibe, evolocumab, alirocumab, statins.

Affiliation:

Centre for Preventive Cardiology, Department of Vascular Medicine, Division of Medicine, University Medical Centre Ljubljana, Ljubljana



Read Full-Text article